ArticleEuropean journal of case reports in internal medicine2024
Failure of the PD-1 Blocking Agent Pembrolizumab to Benefit a Patient with Renal Squamous Cell Cancer.
Salman Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.